(Q44031808)

29 November 2017

title

Ki67 Antigen Expression Correlates with Tumor Progression and HLA-DR Antigen Expression in Melanocytic Lesions (English)

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

1 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

1 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

1 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

1 November 2022

author name string

S. Moretti

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

R. Massobrio

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

L. Brogelli

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

M. Novelli

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

B. Giannotti

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

M. G. Bernengo

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?resulttype=core&format=json&query=SRC%3AMED%20AND%20EXT_ID%3A1696603

1 November 2022

language of work or name

English

0 references

publication date

1 September 1990

1 reference

full work available at URL

29 November 2017

https://api.elsevier.com/content/article/PII:S0022202X9090180E?httpAccept=text/xml

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

https://api.elsevier.com/content/article/PII:S0022202X9090180E?httpAccept=text/plain

1 November 2022

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Journal of Investigative Dermatology

1 November 2022

published in

1 reference

29 November 2017

volume

95

1 reference

29 November 2017

issue

3

1 reference

29 November 2017

page(s)

320-324

1 reference

https://scigraph.springernature.com/pub.10.1111/1523-1747.ep12485060

29 November 2017

exact match

0 references

cites work

Tumor progression in human malignant melanoma: five stages defined by their antigenic phenotypes

2

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Proliferative index in breast carcinoma determined in situ by Ki67 immunostaining and its relationship to clinical and pathological variables

1 November 2022

5

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Ki-67 derived proliferative activity in colorectal adenocarcinoma with prognostic correlations

1 November 2022

6

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

The prognostic value of Ki67 immunostaining in non-Hodgkin's lymphoma

1 November 2022

7

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Production of a mouse monoclonal antibody reactive with a human nuclear antigen associated with cell proliferation

1 November 2022

8

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Growth fractions in malignant non-Hodgkin's lymphomas (NHL) as determined in situ with the monoclonal antibody Ki-67

1 November 2022

9

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Immunohistochemical determination of growth fractions in human permanent cell lines and lymphoid tumours: a critical comparison of the monoclonal antibodies OKT9 and Ki-67

1 November 2022

10

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Major histocompatibility antigens and mononuclear inflammatory infiltrate in benign nevomelanocytic proliferations and malignant melanoma

1 November 2022

11

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Immunohistochemical analysis of malignant melanomas and nevocellular nevi with monoclonal antibodies to distinct monomorphic determinants of HLA antigens

1 November 2022

12

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

HLA-DR Antigen Expression in Primary Melanomas of the Skin

1 November 2022

13

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Phenotypic dynamics of tumor progression in human malignant melanoma

1 November 2022

14

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Differential expression of HLA-DR, DQ, and DP antigens in primary and metastatic melanoma

1 November 2022

15

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

The biologic forms of malignant melanoma

1 November 2022

16

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Thickness, cross-sectional areas and depth of invasion in the prognosis of cutaneous melanoma

1 November 2022

17

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

The correlation of growth fractions with histologic grading and lymph node status in human mammary carcinoma

1 November 2022

18

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Growth fractions in breast cancers determined in situ with monoclonal antibody Ki-67.

1 November 2022

19

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Determination of growth fractions in benign breast disease (BBD) with monoclonal antibody Ki-67

1 November 2022

20

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Immunohistologic evidence for the malignant potential of congenital melanocytic nevi

1 November 2022

21

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Proliferative activity of cutaneous melanocytic tumors defined by Ki-67 monoclonal antibody. A quantitative immunohistochemical study

1 November 2022

23

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Cell kinetics as a prognostic tool in patients with metastatic malignant melanoma of the skin

1 November 2022

24

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

Tumor thickness is not a prognostic factor in thin melanoma

1 November 2022

26

1 reference

https://api.crossref.org/works/10.1111/1523-1747.EP12485060

1 November 2022

Identifiers

1 reference

Dimensions Publication ID

29 November 2017

1011924136

0 references

1 reference